CALIDI BIOTHERAPEUTICS INC (CLDI) Stock Balance Sheet
NYSEARCA:CLDI - American Stock Exchange - US3207033099 - Common Stock
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 836.00K | 1.95M | 93.89K | 1.06M | N/A | |||
| Receivables | 181.00K | N/A | 870.00 | N/A | N/A | |||
| Other Current Assets | 608.00K | 2.35M | 414.00K | 603.00K | 93.00K | |||
| Total Current Assets | 1.63M | 4.30M | 786.00K | 2.74M | 513.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.58M | 5.34M | 1.09M | 585.00K | 723.00K | |||
| Investments And Advances | N/A | 230.00K | 725.00K | 66.00K | 616.00K | |||
| Other Non-Current Assets | 227.00K | 143.00K | 0.00 | 280.94K | N/A | |||
| Total Non-Current Assets | 4.81M | 5.72M | 1.81M | 651.00K | 1.34M | |||
| TOTAL ASSETS | 6.43M | 10.02M | 2.60M | 3.39M | 1.85M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 2.96M | 4.48M | 1.86M | |||
| Current Portion Of LT Debt. | 3.05M | 888.00K | 2.54M | 568.00K | 3.14M | |||
| Accrued Expenses | 4.86M | 6.47M | 5.39M | 3.60M | 1.81M | |||
| Accounts Payable | 4.46M | 2.80M | 2.12M | 510.00K | 822.00K | |||
| Other Current Liabilities | 684.00K | 81.00K | 29.98M | 16.80M | 1.25M | |||
| Total Current Liabilities | 13.05M | 10.23M | 42.99M | 25.96M | 8.89M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.10M | 2.28M | 142.00K | 38.00K | 6.37M | |||
| Other Non-Current Liabilities | 3.03M | 5.75M | 305.00K | 5.00K | 72.00K | |||
| Total Non-Current Liabilities | 5.13M | 8.02M | 447.00K | 43.00K | 6.44M | |||
| TOTAL LIABILITIES | 18.18M | 18.25M | 43.44M | 26.00M | 15.33M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -112.56M | -99.57M | -70.36M | -44.93M | -34.44M | |||
| Additional Paid In Capital | 100.84M | 91.38M | 19.93M | 13.32M | 11.95M | |||
| Common Shares | 1.00K | 4.00K | 9.60M | 9.00M | 9.00M | |||
| Other Shareholders' Equity | -27.00K | -47.00K | -14.00K | -1.00K | 6.00K | |||
| Shares Outstanding | 6.47M | 5.35M | 4.55M | 4.55M | 45.45M | |||
| Tangible Book Value per Share | -1.82 | -1.54 | -11.10 | -6.96 | -0.49 | |||
| Total Shareholders' Equity | -11.75M | -8.23M | -40.84M | -22.61M | -13.48M | |||
| TOTAL LIABILITIES AND EQUITY | 6.43M | 10.02M | 2.60M | 3.39M | 1.85M | |||
| Statistics | ||||||||
| Debt/Equity | -0.18 | -0.28 | -0.08 | -0.20 | -0.61 | |||
| Current Ratio | 0.12 | 0.42 | 0.02 | 0.11 | 0.06 | |||
| Return On Assets (ROA) | -387.44% | -291.61% | -979.09% | -322.41% | -428.56% | |||
All data in USD , ROIC based on taxRate of 0.21